Analysis of transcriptomic data from larger lung cancer patient cohorts, however, revealed increased tumour expression of genes encoding both peroxidasin and ADAMTS16, and this was separately linked to poorer survival of lung adenocarcinoma and squamous cell carcinoma patients, respectively. The gene discussed is PXDN; the disease is lung cancer.